Virological response and safety outcomes in therapy–naïve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study
Robert G. Gish, Sanjeev Arora, K. Rajender Reddy, David R. Nelson, Christopher O’Brien, Yi Xu, Brian MurphyVolume:
47
Year:
2007
Language:
english
DOI:
10.1016/j.jhep.2007.02.018
File:
PDF, 227 KB
english, 2007